Arrowhead Pharmaceuticals · 3 hours ago
Director, Data Integrity
Arrowhead Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing innovative drugs for diseases with a genetic basis. The Director of Data Integrity will provide strategic leadership for the design, implementation, and continuous improvement of the company’s data integrity program across GxP operations, ensuring compliance with global regulations and fostering a culture of data integrity.
BiotechnologyHealth CareNanotechnologyPharmaceutical
Responsibilities
Lead the development, implementation, and continuous improvement of data integrity policies, procedures, and program elements in alignment with global regulatory requirements
Establish and oversee data integrity governance programs, partnering cross-functionally to drive strategic initiatives and foster a culture of data integrity
Develop and maintain systems for data integrity impact assessments, risk evaluations, and remediation plans, ensuring timely completion of commitments
Evaluate data management, documentation, and record control practices across systems and formats to ensure compliance with data integrity requirements
Implement and maintain processes to assess computerized systems, software, and equipment for compliance with 21 CFR Part 11, Annex 11, and related guidance
Lead and oversee comprehensive data integrity audits and assessments to identify risks, gaps, or discrepancies, and lead mitigation and remediation activities
Drive corrective and preventive actions and process improvement initiatives to strengthen data integrity controls and system reliability
Develop, analyze, and report data integrity metrics and key performance indicators to senior leadership
Design and deliver training programs to promote data integrity awareness and ensure consistent understanding across the organization
Provide subject matter expertise and support during regulatory inspections and partner audits, articulating data integrity program elements and strategy
Monitor global regulations, emerging guidance, and best practices through active engagement with relevant professional organizations (e.g., ISPE, PDA)
Perform additional duties as assigned to support objectives
Qualification
Required
Bachelor's degree in science, engineering, information technology, computer science, data management, or a related technical discipline
Minimum of ten (10) years of experience in the regulated pharmaceutical, biotechnology, or combination product industry, including at least five (5) years in a leadership role with increasing responsibility
Comprehensive knowledge of GxP regulations, including GMP (FDA, EU, etc.), ICH guidelines, and ISO standards
Demonstrated expertise with ALCOA++ principles, data lifecycle management, and data governance frameworks
Proven experience applying 21 CFR Part 11, Annex 11, and other relevant regulations and guidance governing data integrity and information security
Strong understanding of information technology and data management systems, including system validation, security, and enterprise data governance
Proven ability to lead complex, cross-functional projects and build effective partnerships to advance data integrity and compliance objectives, demonstrating strong organizational, planning, and prioritization skills
Strategic thinker with demonstrated success in driving continuous improvement, innovation, and proactive risk management
Excellent communication, interpersonal, and leadership skills, with the ability to work with a diverse range of professionals and influence stakeholders at all levels
Ability for occasional business travel
Preferred
Advanced degree preferred
Certification or formal training in quality management, data integrity, data governance, or regulatory compliance (e.g., ASQ, ISPE, PDA, or equivalent)
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Funding
Current Stage
Public CompanyTotal Funding
$1.62BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2024-11-26Post Ipo Equity· $325M
2024-08-08Post Ipo Debt· $400M
2024-01-03Post Ipo Equity· $450M
Leadership Team
Recent News
2025-12-27
Los Angeles Business Journal
2025-12-24
Morningstar.com
2025-12-16
Company data provided by crunchbase